Bio-Rad Laboratories, Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K reports on the Annual Meeting of Stockholders held by Bio-Rad Laboratories, Inc. on April 24, 2012. The filing details the outcomes of three specific matters submitted to a vote by security holders.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results.
Material Changes and Voting Results
The following matters were approved by stockholders:
- Election of Directors: All six nominees were elected. Class A directors (Louis Drapeau, Albert J. Hillman) received over 18 million votes each. Class B directors (Ted W. Love, Deborah J. Neff, Alice N. Schwartz, Norman Schwartz) received over 4.8 million votes each.
- Auditor Ratification: Stockholders ratified the selection of Ernst & Young LLP as the independent auditor for the fiscal year ending December 31, 2012, with 7,228,289 votes for and 10,111 against.
- Executive Compensation: Stockholders approved the material terms of the performance criteria in the 2007 Incentive Award Plan under Section 162(m) of the Internal Revenue Code, with 6,681,309 votes for and 155,159 against.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Key Facts for Investor Verification
- Confirmation that the 2007 Incentive Award Plan performance criteria were approved to ensure compliance with Section 162(m) of the Internal Revenue Code.
- Verification of the continued engagement of Ernst & Young LLP as the independent auditor for the 2012 fiscal year.
- Review of the specific performance metrics approved for the incentive plan to assess executive compensation alignment.